Clicky

Harrow Health, Inc.(HROW) News

Date Title
Jul 17 Harrow Enters into Commercialization Agreement with Samsung Bioepis for Ophthalmology Biosimilars Portfolio in the United States
Jul 14 Harrow (HROW) Stock Jumps 11.4%: Will It Continue to Soar?
Jul 2 Are Options Traders Betting on a Big Move in Harrow Stock?
Jun 26 We Might See A Profit From Harrow, Inc. (NASDAQ:HROW) Soon
Jun 18 Harrow Appoints Mike Biega as Vice President of Investor Relations and Communications
May 5 Harrow to Report First Quarter 2025 Financial Results After Market Close on May 8, 2025
Apr 10 Harrow Expands VEVYE® Access for All Program to ImprimisRx’s Klarity-C Patients
Mar 11 Harrow Executes Five-Year Strategic Supply and Development Agreement for TRIESENCE®
Mar 3 Harrow to Report Fourth Quarter and Year-End 2024 Financial Results After Market Close on March 17, 2025
Feb 26 US Growth Companies With High Insider Ownership To Watch
Feb 18 Harrow (NASDAQ:HROW) shareholders have earned a 40% CAGR over the last five years
Oct 3 Harrow Relaunches TRIESENCE®
Oct 2 Harrow, Inc. (HROW): A Bull Case Theory
Sep 25 Harrow Announces Nashville Expansion
Aug 7 Harrow Announces Second Quarter 2024 Financial Results
Jul 25 Harrow To Report Second Quarter 2024 Financial Results After Market Close on August 7, 2024
Jun 20 Harrow Provides TRIESENCE® Relaunch Update
May 15 Harrow to Present at Two Investor Conferences in May
May 13 Harrow Announces First Quarter 2024 Financial Results
May 13 Harrow Names Greg DiPasquale as Senior Vice President, Head of Commercial